During the past decade, BroMenn Regional Medical Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 146 clinical trials were completed, i.e. on average, 2433.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 28 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "BroMenn Regional Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 90 trials, followed by "National Cancer Institute (NCI)" with 63 trials sponsored, "Eastern Cooperative Oncology Group" with 15 trials sponsored, "SWOG Cancer Research Network" with 15 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "BroMenn Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 157 trials as a collaborator, "NCIC Clinical Trials Group" with 16 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 13 trials as a collaborator and "Eastern Cooperative Oncology Group" with 11 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "BroMenn Regional Medical Center" are "Breast Cancer" (34 trials), "Lung Cancer" (19 trials), "Lymphoma" (17 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (11 trials) and "Leukemia" (10 trials). Many other conditions were trialed in "BroMenn Regional Medical Center" in a lesser frequency.

Most popular intervention types in "BroMenn Regional Medical Center" are "Drug" (184 trials), "Other" (95 trials), "Biological" (85 trials), "Radiation" (41 trials) and "Procedure" (19 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "placebo" (29 trials), "Paclitaxel" (18 trials), "Quality-of-Life Assessment" (18 trials) and "carboplatin" (18 trials). Other intervention names were less common.

The vast majority of trials in "BroMenn Regional Medical Center" are 172 trials for "All" genders, 44 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "BroMenn Regional Medical Center". undefined are not yet recruiting, 6 are recruiting, 45 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 151 completed trials in BroMenn Regional Medical Center, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in BroMenn Regional Medical Center, 14 "Phase 1" clinical trials were conducted, 102 "Phase 2" clinical trials and 104 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".